Medical Condition News

RSS

Camel blood can help scientists fight against cancer

Nanobodies produced from camel blood have unique properties, which can be used in future drug development. New research published in Journal of Controlled Release confirms that camel blood can help scientists in the fight against cancer.

15 Jul 2011

BioMarin commences BMN 673 Phase 1 trial in hematological malignancies

BioMarin Pharmaceutical Inc. today announced the initiation of a Phase 1 trial for BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor, for the treatment of patients with advanced hematological malignancies.

15 Jul 2011

Cancer may soon affect 40% of UK’s population: Report

Macmillan Cancer Support this Thursday revealed warning estimates that four in 10 people in the UK will get cancer at some point in their lives, up from one in three a decade ago. Cancer experts now believe 42% of Britons will get the disease.

14 Jul 2011

Michael J. Fox Foundation awards Impax $400,000 grant for research of IPX066 for Parkinson’s disease

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., has been awarded funding of up to $400,000 by The Michael J. Fox Foundation for ongoing clinical research of the Company's investigational carbidopa-levodopa extended release (CD-LD ER) product IPX066, which is intended to treat the motor symptoms of Parkinson's disease (PD).

14 Jul 2011

Eli Lilly makes charitable contribution to Patient Advocate Foundation

Eli Lilly and Company announced that it has made a charitable contribution to the Patient Advocate Foundation.

14 Jul 2011

Safety guidelines for preventing injuries from gasoline

Summer is in full swing and injuries from gasoline and other accelerants are on the rise. The University of Michigan Health System's Trauma Burn Center saw 14 such burns in the past month.

14 Jul 2011

Two promising projects focus on new treatments for cystic fibrosis

Two promising projects have been selected to undergo preclinical testing as part of the Cystic Fibrosis Technology Initiative.

14 Jul 2011

Study examines psychological problems among adopted children

Over 4,000 international adoptions take place in Spain every year. Although the process of adaptation of these children is very similar to that of those living with their biological parents, some studies show that they are more prone to being hyperactive, to having behavioural problems, a low self-esteem and doing poorly in school.

14 Jul 2011

USPTO awards patent for Convergen LifeSciences' CNVN202 to treat lung cancer

Convergen LifeSciences, Inc. announced today that another United States Patent 7,977,468 has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and Human Services.

14 Jul 2011

New paper provides unique review on respiratory disorders in the Middle East

Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society of Respirology, provides pulmonologists and patients with the first comprehensive review of respiratory illnesses specific to the Persian Gulf region, and the challenges in treating them.

14 Jul 2011

European Respiratory Society Congress to take place on September 24, 2011

The 2011 European Respiratory Society Congress will take place at the Amsterdam RAI congress centre from Saturday 24 September to Wednesday 28 September 2011.

14 Jul 2011

Low optimism appears to predict initiation of psychotherapy

In a study published by a group of Finnish investigators headed by Prof. Karlsson in the current issue of Psychotherapy and Psychosomatics low level of optimism appear to predict initiation of psychotherapy for depression.

14 Jul 2011

EC grants marketing authorization for BENLYSTA to treat SLE

GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorization for BENLYSTA 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.

14 Jul 2011

Study shows benefits of onion waste on human health

More than 500,000 tonnes of onion waste are thrown away in the European Union each year. However, scientists say this could have a use as food ingredients. The brown skin and external layers are rich in fibre and flavonoids, while the discarded bulbs contain sulphurous compounds and fructans. All of these substances are beneficial to health.

14 Jul 2011

IMM researcher wins prestigious Early Career Bayer Hemophilia Award

Vanessa Oliveira, researcher at the Instituto de Medicina Molecular in Portugal won a prestigious and competitive Early Career Bayer Hemophilia Award. Oliveira will develop a strategy to reprogramme the immune system of hemophilia patients to avoid immune targeting of the most used clotting therapeutics.

14 Jul 2011

Study demonstrates how unconscious brain continues to process information

Brain damage can cause significant changes in behaviour, such as loss of cognitive skills, but also reveals much about how the nervous system deals with consciousness. New findings reported in the July 2011 issue of Elsevier's Cortex demonstrate how the unconscious brain continues to process information even when the conscious brain is incapacitated.

14 Jul 2011

New low-energy method for terminating cardiac fibrillation

An international team of scientists from the Max-Planck-Institute for Dynamics and Self-Organization, Cornell University the Ecole Normale Supérieure de Lyon, the University Medicine Göttingen, the Rochester Institute of Technology, and the Institut Non-Linéaire de Nice have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart.

14 Jul 2011

New less painful technique to end life-threatening heart fibrillations

Cornell scientists, in collaboration with physicists and physician-scientists in Germany, France and Rochester, N.Y., have developed a new - and much less painful and potentially damaging - method to end life-threatening heart fibrillations.

14 Jul 2011

No single approach might effectively improve Americans' dietary behavior, health

Will people eat healthier foods if fresh fruits and vegetables are available in stores near their homes? Will they eat less fast food if restaurants are not in their neighborhoods? These and other policy interventions may be useful steps toward better public health, but no single approach alone will effectively improve Americans' diets or stem the obesity epidemic, concludes a study by researchers at the University of North Carolina at Chapel Hill.

14 Jul 2011

RXi expands intellectual property portfolio with additional NeuVax patents

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.

14 Jul 2011